Supportive Care in Cancer

, Volume 18, Issue 5, pp 583–590 | Cite as

Development of the MASCC teaching tool for patients receiving oral agents for cancer

  • Sultan KavEmail author
  • Lisa Schulmeister
  • Anita Nirenberg
  • Linda Barber
  • Judi Johnson
  • Cynthia Rittenberg
Original Article



Oral agents for cancer treatment commonly are prescribed throughout the world. Since oral agents usually are self-administered or administered by lay caregivers, patient education is vital to help ensure that the oral agents are being stored, handled, and taken correctly. When oral agents are taken as prescribed and patients are well informed about signs and symptoms to report, patient outcomes are optimized. Patient education varies globally; consequently, there is a need for a consistent and comprehensive approach to educate patients about oral cancer treatment.

Goal of work

To create a teaching tool to be used with patients receiving oral cancer agents for worldwide use.

Materials and methods

Six oncology nurse experts conducted a literature review and convened as an expert panel to draft a teaching tool for patients receiving oral cancer agents. The tool includes key assessment questions, generic education discussion points, drug-specific education, and evaluation questions to help ensure that patients/caregivers understand the information provided. Eighteen healthcare providers from 15 countries reviewed the tool for clarity and usefulness in practice by scoring each item in the teaching tool on a 0–10 scale (“0 = not at all to “10” = most clear/useful”). Items that scored 5 or below required comments. At the Multinational Association for Supportive Care in Cancer (MASCC) Symposium in 2008, the healthcare providers who reviewed the teaching tool met with the oncology nurse experts who had developed the tool to review the item scores and revise the tool as necessary.


All items on the teaching tool received high scores, with the exception of items on refilling prescriptions and insurance issues, which vary from country to country. There was consensus that the MASCC Teaching Tool for Patients Receiving Oral Agents for Cancer was ready to be used and further evaluated in clinical practice.


The MASCC Teaching Tool for Patients Receiving Oral Agents for Cancer is an available resource to assist healthcare providers assess and teach patients about oral cancer treatment.


Oral agents for cancer Treatment adherence Patient teaching tool 



The authors would like to thank all the nurse coordinators (Annette Dahler—Australia; Jing Chen—China; Linette Poulsen—Denmark; Elisabeth Patiraki and Anna Papadouri—Greece; David Makumi—Kenya; Jolanta Toliusiene—Lithuania; Hanan Saca Hazboun—Palestine; Dusanka Tadic—Serbia; Paz Fernandez—Spain; Syvesta Hildegard—South Africa; Pongpak Pittayapan—Thailand; Annie Young—UK; Rebecca Clark-Snow, Elsie Anderson, June Eilers, and Sandra Siehl—USA; and Pharmacist Vijay Roy—India) who attended to the program, Mark Holdsworth, PharmD, BCOS, University of New Mexico, USA for reviewing the tool, members of the MASCC Education Study Group, and MASCC, Eli Lilly, OSI Pharmaceutical Company, and Celgene Corporation for their financial support.


  1. 1.
    Bartel S (2007) Safe practices and financial considerations in using oral chemotherapy agents. Am J Health Syst Pharm 64(9 Suppl 5):S8–S14CrossRefPubMedGoogle Scholar
  2. 2.
    Findlay M, von Minckwitz G, Wardley A (2008) Effective oral chemotherapy for breast cancer: pillars of strength. Ann Oncol 19(2):212–222CrossRefPubMedGoogle Scholar
  3. 3.
    Hartigan K (2003) Patient education: the cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs 7(6):21–24CrossRefPubMedGoogle Scholar
  4. 4.
    Hilton A, Skrutkowski M (2002) Translating instruments into other languages: development and testing processes. Cancer Nurs 25(1):1–7CrossRefPubMedGoogle Scholar
  5. 5.
    Jones P, Lee J, Phiollips L, Zhang X, Jaceldo KJ (2001) An adaptation of Brislin’s Translation Model for cross-cultural research. Nurs Res 50(5):300–304CrossRefPubMedGoogle Scholar
  6. 6.
    Kav S, Bostanci H (2006) Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey. Support Care Cancer 14(12):1252–1257CrossRefPubMedGoogle Scholar
  7. 7.
    Kav S, Johnson J, Rittenberg C, Fernadez-Ortega P, Suominen T, Olsen PR, Patiraki E, Porock D, Dahler A, Toliusiene J, Tadic D, Pittayapan P, Roy V, Wang Q, Colak M, Saca-Hazboun H, Makumi D, Kadmon I, Ami SB, Anderson E, Clark-Snow R (2008) Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment: an International survey. Support Care Cancer 16:1075–1083CrossRefPubMedGoogle Scholar
  8. 8.
    Moore S (2007) Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs 30(2):112–122CrossRefPubMedGoogle Scholar
  9. 9.
    Ruddy K, Mayer E, Partridge A (2009) Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 59(1):56–66CrossRefPubMedGoogle Scholar
  10. 10.
    Viele CS (2007) Managing oral chemotherapy: the healthcare practitioner’s role. Am J Health Syst Pharm 64(9 Suppl 5):S25–S32CrossRefPubMedGoogle Scholar
  11. 11.
    Wyatt K, Carter M, Mahtani V, Barnard A, Hawton A, Britten N (2008) The impact of consumer involvement in research: an evaluation of consumer involvement in the London Primary Care Studies Programme. Fam Pract 25:154–161CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Sultan Kav
    • 1
    Email author
  • Lisa Schulmeister
    • 2
  • Anita Nirenberg
    • 3
  • Linda Barber
    • 4
  • Judi Johnson
    • 5
  • Cynthia Rittenberg
    • 5
  1. 1.Faculty of Health Sciences, Department of NursingBaskent UniversityBaglicaTurkey
  2. 2.River RidgeUSA
  3. 3.School of NursingColumbia UniversityNew YorkUSA
  4. 4.Pharmaceutical Product Development, Inc.MorrisvilleUSA
  5. 5.Multinational Association of Supportive Care in CancerMetairieUSA

Personalised recommendations